VIP-immunoreactivity occurs in a number of tumors, and VIPR1 is overexpressed, resulting in high densities, in numerous cancers including bladder, breast, colon, lung, pancreatic, and prostate cancers (22, 23), although there are some inconsistencies with other studies (24, 25). This evidence concerns the gene VIPR1 and cancer.